Catalyst Wire Dossier Catalyst Wire Dossier

Ruxolitinib Cream

ruxolitinib · Incyte Corporation
Drug timelines are a Plus or Pro feature.

23 regulatory and trial events tracked for Ruxolitinib Cream, covering 2021-12-17 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1) [Phase 3]

See pricing